Article
Characterizing the protective effects of SHLP2, a mitochondrial-derived peptide, in macular degeneration
5 Oct 2018
Abstract excerpt
Mitochondrial-derived peptides (MDPs) are rapidly emerging therapeutic targets to combat development of neurodegenerative diseases. SHLP2 (small humanin-like peptide 2) is a newly discovered MDP that is coded from the MT-RNR2 (Mitochondrially encoded 16S rRNA) gene in mitochondrial DNA (mtDNA). In the current study, we examined the biological consequences of treatment with exogenously-added SHLP2 in an in vitro...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
